LATE BREAKER - Primary Results of VASCEPA







Are we saved?!

First Human Trial of a Loading Dose of Icosapent Ethyl in Patients with COVID-19.

We’re in a pandemic! If positive, why wait 2 weeks. Let’s save the world!

First Human Trial of a Loading Dose of Icosapent Ethyl in Patients with COVID-19: Primary Results of the VASCEPA COVID-19 CardioLink-9 Randomized Trial

Speaker: Deepak L. Bhatt, MD, MPH
Saturday, December 12
4:30 - 5:15pm